Ongoing COVID19 Research Projects
| SN | Title of Research | Department |
| 1 | Association of The Prophylactic Measures Adopted With The Severity Of Disease In The Confirmed Cases Of COVID-19 In Police of Nashik District : An Observational Study | Physiology |
| 2 | An Epidemiological Study to Identify the Socio-Demographic Determinants of COVID 19 Infection And Recommend Interventional Strategies | Community Medicine |
| 3 | Comparative Study of Various Biochemical Parameters in COVID-19 Positive Patients – Stage I | Biochemistry |
| 4 | Study Of Pulse Rate, Oxygen Saturation And Respiratory Rate In Progression Of Covid-19 Disease – An Observational Study | Anesthesiology |
| 5 | A Cross Sectional Study of Psychological Impact of Covid-19 Pandemic among Healthcare Workers in India | Psychiatry |
| 6 | C-Reactive Protein (CRP) And Serum Ferritin Levels as a Prognostics Indicator in Indian COVID-19 Positive Cases Admitted in ICU at Tertiary Care Unit | General Medicine |
| 7 | Study of Asymptomatic Urinary Abnormalities in COVID-19 Positive Patients Admitted to a Tertiary Care Hospital | General Medicine |
| 8 | Study of Prothrombotic Parameters as Markers of Severity in COVID-19 Positive Patients Admitted to a Tertiary Care Hospital | General Medicine |
| 9 | Perception of Medical Undergraduate students towards Online Education during COVID19 pandemic | Physiology, Community Medicine, Pharmacology |
Ongoing Clinical Trials
| Sr. No | Name of trial | Study Code/ Number | Principal Investigator | Department | Sponsor | Status & Year |
| 1 | A phase IV, prospective, multi-centric, double-blind, comparative, clinical study to compare the efficacy and safety of intravenous ulinastatin versus placebo along with standard supportive care in subjects with severe sepsis. | BSV-UTI-IV-614 | Dr. Neelima Chafekar | Medicine | Bharat Serums & Vaccines Limited | Ongoing 2016 |
| 2 | A Multicentric, Randomized, Prospective,Open Label, Comparative,Parallel Group Clinical Trial to Evaluate the Efficacy and Safety of Fixeddose combination of Trypsin – Chymotrypsin Enzyme and Diclofenac Oral Tablet in comparison with Diclofenac oral Tablet in the management of acute inflammation due to soft tissue injuries. | CT/TRYP+CHYM+DICL/STI//15 | PI-Dr.Sudhir Bhamre
|
Surgery | Torrent pharmaceuticals Ltd. | Ongoing 2017 |
| 3 | A Prospective, Multicenter, Randomized, Double-Blind, Phase 3 Study to Evaluate the Safety and Efficacy ofa Gel Formulation of Esmolol Hydrochloride (Galnobax@) in Treating Diabetic Foot Ulcers. | NG-A16 | PI-Dr.Sudhir Bhamre
|
Surgery | JSS Medical Research India Private Ltd Monitoring (Novalead Pharma) | Ongoing 2019 |
| 4 | Safety and Efficacy of Transarterial Chemoembolization with Lipiodol® in the treatment of inoperable Hepatocellular Carcinoma (HCC) in Indian Patients. | LUF-44-005 | PI-Dr. Soham Doshi
|
Medicine | Guerbet medical expert | Ongoing 2020 |
| 5 | A Multicentric, Randomized, Open Label, Parallel group, Comparative Controlled Phase III Trial to evaluate the Efficacy and Safety of Fixed Dose Combination of Bisoprolol 2.5 mg / 5 mg and Telmisartan 40 mg / 40 mg tablet in subjects with mild to moderate hypertension. | PI:Dr Sandip Chaudhary
|
Medicine | In process 2021 | ||
| 6 | A Multicenter, Prospective, Randomized, Double Blind, Parallel groupPlacebo Controlled Clinical End Point study of Ozenoxacin topical cream 1% in malesand non Pregnant, non lactating females with Impetigo. | Dr. V.P Zawar | Dermatology | In process 2021 | ||
| 7 | A Phase III, Prospective, Randomized, Open-label, Parallel-group,Multicenter Clinical Trial to Compare the Efficacy and Safety of Single-pill Fixed dosecombination of Dapagliflozin plus Teneligliptin (10 mg + 20 mg) versus Teneligliptin20 mg in Treatment of Patients with Inadequately Controlled Type 2 Diabetes Mellitus | Dr. Sandip Chaudhari | Medicine | In process 2021 | ||
| 8 | A randomized, double blind, multicentric, placebo controlled, parallel group clinical trial to evaluate the efficacy and safety of Plecanatide in subjects with chronic idiopathic constipation or irritable bowel syndrome with constipation | Dr.Madhuri Kirloskar | Medicine | M/s.MSN Laboratories Private Limited | In process 2021 | |
| 9 | A randomized, double blind, placebo-contro Iled study to evaluate safety and efficacy ofIP with Standard ofCare (SOC) vs. Placebo with SOC in hospitalized patients with severe COVID-19. | SE/2IO4O IAJM/COVID | Dr. Mayur Devraj | TB &Chest | Vedic Lifesciences | In process 2021 |
| 10 | A randomized, open label, two arm, multicenter, prospective, clinical study to evaluate efficacy and safety of HRPT-091514 as an adjuvant to standard of care in subjects with chronic kidney disease. | Interventional | Dr.Abhijit More | Medicine | Himalaya | In process 2022 |